Regan Andrew bought CDT
September 19, 2025 · Form 4 insider transaction
Regan Andrew bought 1,120,000 shares of CDT Equity Inc. at $0.69 per share, a transaction worth $768.7K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,120,000
Price
$0.69
Total value
$768.7K
InsiderRegan Andrew
Role—
CompanyCDT Equity Inc. (CDT)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateSeptember 19, 2025
Filing dateSeptember 22, 2025
Shares owned after1,120,044
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On September 19, 2025, CDT Equity Inc. (formerly known as Conduit Pharmaceuticals Inc. (the "Issuer")) granted Dr. Andrew Regan ("Dr. Regan") 1,120,000 shares of common stock, par value $0.0001 ("Common Stock"), of the Issuer pursuant to the Issuer's Amended and Restated 2023 Stock Incentive Plan as compensation for his services as a director and an officer of the Issuer.; Based on the closing price per share of Common Stock on September 18, 2025.